Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
3903 ARTÍCULOS , VIENDO DEL 1201 AL 1215
The pathogenesis of Pisa syndrome in Parkinson's disease
Castrioto A, Piscicelli C, Pérennou D, Krack P, Debû B.
Mov Disord. 2014 Aug;29(9):1100-7. doi: 10.1002/mds.25925. Epub 2014 Jun 7.
Gastric bezoar complication of Duodopa(®) therapy in Parkinson's disease, treated with Coca-Cola(®)
Stathis P, Tzias V, Argyris P, Barla G, Maltezou M.
Mov Disord. 2014 Jul;29(8):1087-8. doi: 10.1002/mds.25930. Epub 2014 Jun 7.
Homozygous TREM2 mutation in a family with atypical frontotemporal dementia
Le Ber I, De Septenville A, Guerreiro R, Bras J, Camuzat A, Caroppo P, Lattante S, Couarch P, Kabashi E, Bouya-Ahmed K, Dubois B, Brice A.
Neurobiol Aging. 2014 Oct;35(10):2419.e23-2419.e25. doi: 10.1016/j.neurobiolaging.2014.04.010. Epub 2014 Apr 18.
The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling
Clark CA, Dagher A.
Front Behav Neurosci. 2014 May 30;8:196. doi: 10.3389/fnbeh.2014.00196. eCollection 2014.
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD
Hansen FH, Skjørringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, Law I, Pinborg LH, Sitte HH, Loland C, Shi L, Weinstein H, Galli A, Hjermind LE, Møller LB, Gether U.
J Clin Invest. 2014 Jul;124(7):3107-20. doi: 10.1172/JCI73778. Epub 2014 Jun 9.
Exosomes in neurologic and psychiatric disorders
Tsilioni I, Panagiotidou S, Theoharides TC.
Clin Ther. 2014 Jun 1;36(6):882-8. doi: 10.1016/j.clinthera.2014.05.005. Epub 2014 Jun 7.
Glucocerebrosidase deficits in sporadic Parkinson disease
Murphy KE, Halliday GM.
Autophagy. 2014 Jul;10(7):1350-1. doi: 10.4161/auto.29074. Epub 2014 May 15.
Jaumotte JD, Zigmond MJ.
J Neurosci Res. 2014 Nov;92(11):1425-33. doi: 10.1002/jnr.23425. Epub 2014 Jun 11.
The role of subcutaneous infusion of apomorphine in Parkinson's disease
Wenzel K, Homann CN, Fabbrini G, Colosimo C.
Expert Rev Neurother. 2014 Jul;14(7):833-43. doi: 10.1586/14737175.2014.928202. Epub 2014 Jun 11.
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
Noorbakhsh F, Baker GB, Power C.
Front Cell Neurosci. 2014 Jun 3;8:134. doi: 10.3389/fncel.2014.00134. eCollection 2014.
Creativity, brain, and art: biological and neurological considerations
Zaidel DW.
Front Hum Neurosci. 2014 Jun 2;8:389. doi: 10.3389/fnhum.2014.00389. eCollection 2014.
The Correlation between Osteoporosis Occurrences in Both Schizophrenia and Parkinson's Disease
Radaei F, Darvishi A, Gharibzadeh S.
Front Neurol. 2014 Jun 2;5:83. doi: 10.3389/fneur.2014.00083. eCollection 2014.
Mechanisms of body weight fluctuations in Parkinson's disease
Kistner A, Lhommée E, Krack P.
Front Neurol. 2014 Jun 2;5:84. doi: 10.3389/fneur.2014.00084. eCollection 2014.
Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 - 2013)
Kethiri RR, Bakthavatchalam R.
Expert Opin Ther Pat. 2014 Jul;24(7):745-57. doi: 10.1517/13543776.2014.907275. Epub 2014 Jun 11.
Metabolomics of human brain aging and age-related neurodegenerative diseases
Jové M, Portero-Otín M, Naudí A, Ferrer I, Pamplona R.
J Neuropathol Exp Neurol. 2014 Jul;73(7):640-57. doi: 10.1097/NEN.0000000000000091.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.